Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis

Annals of Noninvasive Electrocardiology

Volumn 16, Issue 1, 2011, Pages 70-76

  Schuller, Joseph L ^a   Lowery, Christopher M ^a   Zipse, Matthew ^a   Aleong, Ryan G ^a   Varosy, Paul D ^a   Weinberger, Howard D ^a   Sauer, William H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

electrophysiology ventricular tachycardia < clinical; noninvasive techniques; signal averaged ECG < clinical

Indexed keywords

ADULT; ARTICLE; BIOPSY; COHORT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HEART SARCOIDOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; QRS COMPLEX; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SIGNAL AVERAGED ELECTROCARDIOGRAPHY;

ADULT; AGED; CARDIOMYOPATHIES; FEMALE; HEART CONDUCTION SYSTEM; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR;

EID: 79251545813     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2010.00411.x     Document Type: Article

References (17)

1. Chapelon-Abric C, de ZD, Duhaut P, et al,. Cardiac sarcoidosis: A retrospective study of 41 cases. Medicine 2004; 83: 315-334.
2. Silverman KJ, Hutchins GM, Bulkley BH,. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211.
3. Epstein AE, DiMarco JP, Ellenbogen KA, et al,. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-e408.
4. Tavora F, Cresswell N, Li L, et al,. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 2009; 104: 571-577.
5. Perry A, Vuitch F,. Causes of death in patients with sarcoidosis: A morphologic study of 38 autopsies with clinicopathologic correlations. Archives of Pathology & Laboratory Medicine 1995; 119: 167-172.
6. Roberts WC, McAllister HA, Ferrans VJ,. Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients and review of 78 previously described necropsy patients. Am J Med 1977; 63: 86-108.
7. Winters SL, Cohen M, Greenberg S, et al,. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991; 18: 937-943.
8. Bauer A, Guzik P,., Barthel P, et al,. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J 2005; 26: 755-761.
9. Nasir N, Rutberg J, Tandri H, et al,. Utility of SAECG in arrhythmogenic right ventricular dysplasia. Annals of Noninvasive Electrocardiology 2003; 8: 112-120.
10. Mancini DM, Wong KL, Simson MB,. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation 1993; 87: 1083-1092.
11. Fauchier L, Babuty D, Cosnay P, et al,. Long-term prognostic value of time domain analysis of signal-averaged electrocardiography in idiopathic dilated cardiomyopathy. Am J Cardiol 2000; 85: 618-623.
12. Hiraga H, Yuwai K, Hiroe M, et al,. Guideline for the diagnosis of cardiac sarcoidosis: Study report on diffuse pulmonary diseases [in Japanese] 1993,23-24 Ministry of Health and Welfare. Tokyo, Japan.
13. Goldberger JJ, Cain ME, Hohnloser SH, et al,. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 2008; 118: 1497-1518.
14. Soejima K, Yada H,. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: With emphasis on the associated heart rhythm abnormalities. Journal of Cardiovascular Electrophysiology 2009; 20: 578-583.
15. Tadamura E, Yamamuro M, Kubo S, et al,. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation 2006; 113: e771-e773.
16. Smedema JP, Snoep G, Van Kroonenburgh MP, et al,. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-1690.
17. Japanese Ministry of Health and Welfare. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis and Granulomatous Disorders 2007; 27: 89-102.